Copyright Reports & Markets. All rights reserved.

Global Rheumatology Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Disease Modifying Anti-rheumatic Drugs
    • 1.2.3 Nonsteroidal Anti-inflammatory Drugs
    • 1.2.4 Corticosteroids
    • 1.2.5 Uric Acid Drugs
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Rheumatology Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Rheumatology Drugs Market Perspective (2016-2027)
  • 2.2 Rheumatology Drugs Growth Trends by Regions
    • 2.2.1 Rheumatology Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Rheumatology Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Rheumatology Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Rheumatology Drugs Industry Dynamic
    • 2.3.1 Rheumatology Drugs Market Trends
    • 2.3.2 Rheumatology Drugs Market Drivers
    • 2.3.3 Rheumatology Drugs Market Challenges
    • 2.3.4 Rheumatology Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Rheumatology Drugs Players by Revenue
    • 3.1.1 Global Top Rheumatology Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
  • 3.4 Global Rheumatology Drugs Market Concentration Ratio
    • 3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2020
  • 3.5 Rheumatology Drugs Key Players Head office and Area Served
  • 3.6 Key Players Rheumatology Drugs Product Solution and Service
  • 3.7 Date of Enter into Rheumatology Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatology Drugs Breakdown Data by Type

  • 4.1 Global Rheumatology Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2022-2027)

5 Rheumatology Drugs Breakdown Data by Application

  • 5.1 Global Rheumatology Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Rheumatology Drugs Market Size (2016-2027)
  • 6.2 North America Rheumatology Drugs Market Size by Type
    • 6.2.1 North America Rheumatology Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Rheumatology Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Rheumatology Drugs Market Size by Type (2016-2027)
  • 6.3 North America Rheumatology Drugs Market Size by Application
    • 6.3.1 North America Rheumatology Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Rheumatology Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Rheumatology Drugs Market Size by Application (2016-2027)
  • 6.4 North America Rheumatology Drugs Market Size by Country
    • 6.4.1 North America Rheumatology Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Rheumatology Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Rheumatology Drugs Market Size (2016-2027)
  • 7.2 Europe Rheumatology Drugs Market Size by Type
    • 7.2.1 Europe Rheumatology Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Rheumatology Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Rheumatology Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Rheumatology Drugs Market Size by Application
    • 7.3.1 Europe Rheumatology Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Rheumatology Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Rheumatology Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Rheumatology Drugs Market Size by Country
    • 7.4.1 Europe Rheumatology Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Rheumatology Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Rheumatology Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Rheumatology Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Rheumatology Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Rheumatology Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Rheumatology Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Rheumatology Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Rheumatology Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Rheumatology Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Rheumatology Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Rheumatology Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Rheumatology Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Rheumatology Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Rheumatology Drugs Market Size (2016-2027)
  • 9.2 Latin America Rheumatology Drugs Market Size by Type
    • 9.2.1 Latin America Rheumatology Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Rheumatology Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Rheumatology Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Rheumatology Drugs Market Size by Application
    • 9.3.1 Latin America Rheumatology Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Rheumatology Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Rheumatology Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Rheumatology Drugs Market Size by Country
    • 9.4.1 Latin America Rheumatology Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Rheumatology Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Rheumatology Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Rheumatology Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Rheumatology Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Rheumatology Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Rheumatology Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Rheumatology Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Rheumatology Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Rheumatology Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Rheumatology Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Rheumatology Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Rheumatology Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Rheumatology Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Takeda Pharmaceutical
    • 11.1.1 Takeda Pharmaceutical Company Details
    • 11.1.2 Takeda Pharmaceutical Business Overview
    • 11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
    • 11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.1.5 Takeda Pharmaceutical Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Rheumatology Drugs Introduction
    • 11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.2.5 Sanofi Recent Development
  • 11.3 Genentech
    • 11.3.1 Genentech Company Details
    • 11.3.2 Genentech Business Overview
    • 11.3.3 Genentech Rheumatology Drugs Introduction
    • 11.3.4 Genentech Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.3.5 Genentech Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Company Details
    • 11.4.2 Novartis Business Overview
    • 11.4.3 Novartis Rheumatology Drugs Introduction
    • 11.4.4 Novartis Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.4.5 Novartis Recent Development
  • 11.5 Janssen Biotech
    • 11.5.1 Janssen Biotech Company Details
    • 11.5.2 Janssen Biotech Business Overview
    • 11.5.3 Janssen Biotech Rheumatology Drugs Introduction
    • 11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.5.5 Janssen Biotech Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Rheumatology Drugs Introduction
    • 11.6.4 Amgen Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 AbbVie
    • 11.7.1 AbbVie Company Details
    • 11.7.2 AbbVie Business Overview
    • 11.7.3 AbbVie Rheumatology Drugs Introduction
    • 11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.7.5 AbbVie Recent Development
  • 11.8 Pfizer
    • 11.8.1 Pfizer Company Details
    • 11.8.2 Pfizer Business Overview
    • 11.8.3 Pfizer Rheumatology Drugs Introduction
    • 11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.8.5 Pfizer Recent Development
  • 11.9 Bristol-Myers Squibb Company
    • 11.9.1 Bristol-Myers Squibb Company Company Details
    • 11.9.2 Bristol-Myers Squibb Company Business Overview
    • 11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
    • 11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.9.5 Bristol-Myers Squibb Company Recent Development
  • 11.10 Merck & Co.
    • 11.10.1 Merck & Co. Company Details
    • 11.10.2 Merck & Co. Business Overview
    • 11.10.3 Merck & Co. Rheumatology Drugs Introduction
    • 11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2016-2021)
    • 11.10.5 Merck & Co. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Rheumatology Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Disease Modifying Anti-rheumatic Drugs
    Nonsteroidal Anti-inflammatory Drugs
    Corticosteroids
    Uric Acid Drugs
    Others

    Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Takeda Pharmaceutical
    Sanofi
    Genentech
    Novartis
    Janssen Biotech
    Amgen
    AbbVie
    Pfizer
    Bristol-Myers Squibb Company
    Novartis

    Buy now